Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.
|Poll|July 3, 2019
Which claim denial do you run into most often?
Although many insurance denials can be avoided, these are some of the most common reasons for denials. Which one do you most often encounter?
Advertisement
Although many insurance denials can be avoided, these are some of the most common reasons for denials. Which one do you most often encounter?
Advertisement
Related to this article
A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
A new study finds that low birth volume and unprofitability were strongly associated with both obstetric unit and full hospital closures between 2010 and 2023.
A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
Fezolinetant was linked to VMS and sleep improvements by week 4 in the real-world OPTION-VMS study, presented at the International Menopause Society World Congress.
Wen Shen, MD, highlights perimenopause as an important period for identifying health risks and supporting healthy aging beyond the menopausal transition.
A global consensus published in The Lancet has officially renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, a change with broad implications for diagnosis, care, and cardiometabolic screening.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Wen Shen, MD, highlights pregnancy, comorbidity history in perimenopause care
2
IMS: Fezolinetant's improvements in sleep quality, hot flashes as early as week 4
3
Preeclampsia Foundation launches postpartum recovery videos for HDP
4
Top headlines in women's health from September 2026
5